MedPath

Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study

Phase 3
Completed
Conditions
Ulcerative Colitis
Inflammatory Bowel Disease
Interventions
Registration Number
NCT00486031
Lead Sponsor
Bausch Health Americas, Inc.
Brief Summary

The objective of the study is to evaluate the long-term safety and tolerability of treatment with balsalazide disodium tablets in subjects who are in remission from ulcerative colitis or who have mildly to moderately active UC.

Detailed Description

The objective of the study is to evaluate the long-term safety and tolerability of treatment with balsalazide disodium tablets in subjects who are in remission from ulcerative colitis or who have mildly to moderately active UC.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
443
Inclusion Criteria
  • Subject has a documented history of UC and is either in remission or currently presents with mildly to moderately active UC symptoms as determined by the investigator upon subject interview of UC symptoms, (e.g., urgency, bowel frequency, and rectal bleeding). Additionally, the diagnosis of UC must be confirmed by past flexible sigmoidoscopy/colonoscopy which may include colonic mucosal pathological findings on biopsy consistent with UC.
  • Subject is capable and willing to comply with all study procedures.
Exclusion Criteria
  • Subject has a history of allergy or intolerance to aspirin, mesalamine or other salicylates.
  • Subject has participated in an investigational drug or device study, other than a previous balsalazide disodium tablet trial (i.e., BZUC3002 or BZUC3003), within 30 days of entering the current study.
  • Subject discontinued from a previous balsalazide disodium tablet study due to study drug-related AE(s), including UC flare or associated symptoms that were perceived by the subject/investigator as being caused by study drug.
  • Subject has had any prior bowel surgery, except appendectomy and cholecystectomy.
  • Subject has unstable cardiovascular, coagulopathy, or pulmonary disease.
  • Regular use of nonsteroidal anti-inflammatory drugs (NSAIDS) except cardioprotective ASA (i.e., less than or equal to 162 mg ASA per day).
  • Subject has a history of human immunodeficiency virus (HIV) or hepatitis (B and C). Subjects with a history of hepatitis B and C will be eligible provided the screening LFTs are within normal limits.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
balsalazide disodium tablets,3.3 g BID,Balsalazide Disodium-
Primary Outcome Measures
NameTimeMethod
Incidence of Treatment Emergent AEs24 Months

Incidence of treatment emergent adverse events

Secondary Outcome Measures
NameTimeMethod
Time to Onset of AEs24 Months

Time to onset of adverse events

Trial Locations

Locations (94)

Community Clinical Trials

🇺🇸

Orange, California, United States

Premeire Pharmaceutical Research

🇺🇸

Tempe, Arizona, United States

Digestive and Liver Disease Specialists

🇺🇸

Norfolk, Virginia, United States

The GI Group of South Jersey

🇺🇸

Vineland, New Jersey, United States

Simon Lichtiger, MD

🇺🇸

New York, New York, United States

North Texas Gastroenterology

🇺🇸

Lewisville, Texas, United States

West Gastroenterology Medical Group

🇺🇸

Los Angeles, California, United States

Houston Digestive Diseases Clinic

🇺🇸

Houston, Texas, United States

Digestive Disease Association

🇺🇸

Baltimore, Maryland, United States

Digestive Disorders Associates

🇺🇸

Annapolis, Maryland, United States

Metro Gastroenterology Group

🇺🇸

Chevy Chase, Maryland, United States

Sharp Rees-Stealy Medical

🇺🇸

San Diego, California, United States

Consultants for Clinical Research, Inc.

🇺🇸

Cincinnati, Ohio, United States

Gastroenterology Clinic of San Antonio

🇺🇸

San Antonio, Texas, United States

Sooner Clinical Research

🇺🇸

Oklahoma City, Oklahoma, United States

Gastrointestinal Institute, PLLC

🇺🇸

Nashville, Tennessee, United States

Nashville Medical Research Institute

🇺🇸

Nashville, Tennessee, United States

Birmingham Gastroenterology Associates, PC

🇺🇸

Birmingham, Alabama, United States

Wisconsin Center for Advanced Research

🇺🇸

Milwaukee, Wisconsin, United States

George Koval, M.D.

🇺🇸

Portland, Oregon, United States

Discovery Research International

🇺🇸

Milwaukee, Wisconsin, United States

Clinical Research Institute of Michigan LLC

🇺🇸

Chesterfield, Michigan, United States

Gastroenterology United of Tulsa

🇺🇸

Tulsa, Oklahoma, United States

Austin Gastroenterology

🇺🇸

Austin, Texas, United States

AGMG Clinical Research Institute

🇺🇸

Anaheim, California, United States

Discovery Clinical Research, Inc.

🇺🇸

Encinitas, California, United States

Arapahoe Gastrroenterology, PC

🇺🇸

Littleton, Colorado, United States

South Denver Gastroenterology

🇺🇸

Lone Tree, Colorado, United States

Southern Clinical Research Consultants

🇺🇸

Hollywood, Florida, United States

Clinical Trials Management of Boca Raton

🇺🇸

Boca Raton, Florida, United States

Rocky Mountain Gastroenterology

🇺🇸

Lakewood, Colorado, United States

Connecticut Gastroenterology Institute

🇺🇸

Bristol, Connecticut, United States

Research Consultants Group

🇺🇸

Hialeah, Florida, United States

Mark Lamet, M.D.

🇺🇸

Hollywood, Florida, United States

A+ Research

🇺🇸

Miami, Florida, United States

United Medical Research

🇺🇸

New Smyrna Beach, Florida, United States

Venture Research Institute, LLC

🇺🇸

North Miami Beach, Florida, United States

Shafran Gastroenterology Center

🇺🇸

Winter Park, Florida, United States

Florida Medical Clinic, PA

🇺🇸

Zephyrhills, Florida, United States

Dekalb Gastroenterology Associates

🇺🇸

Decatur, Georgia, United States

Gastroenterology Associates of Central Georgia

🇺🇸

Macon, Georgia, United States

Atlanta Gastroenterology Associates

🇺🇸

Atlanta, Georgia, United States

Digestive Research Associates

🇺🇸

Newnan, Georgia, United States

University Digestive Health Center

🇺🇸

Oak Forest, Illinois, United States

Carle Clinic Association

🇺🇸

Urbana, Illinois, United States

Iowa Digestive Disease Center, PC

🇺🇸

Clive, Iowa, United States

Community Clinical Research Center

🇺🇸

Anderson, Indiana, United States

Digestive Health Center of Louisiana

🇺🇸

Baton Rouge, Louisiana, United States

Clinical Trials Management

🇺🇸

Metairie, Louisiana, United States

Charm City Research

🇺🇸

Lutherville, Maryland, United States

Washington County Hospital

🇺🇸

Hagerstown, Maryland, United States

Alan Rosen, M.D.

🇺🇸

Baltimore, Maryland, United States

Philip J. Bean Medical Center

🇺🇸

Hollywood, Maryland, United States

Shore Health Group

🇺🇸

Ocean City, New Jersey, United States

St. Louis Center for Clinical Research

🇺🇸

Saint Louis, Missouri, United States

Coastal Research Associates, Inc.

🇺🇸

Braintree, Massachusetts, United States

Gastroenterology Associates of West Michigan

🇺🇸

Grand Rapids, Michigan, United States

Center for Digestive and Liver Diseases

🇺🇸

Mexico, Missouri, United States

Gastrointestinal Associates

🇺🇸

Jackson, Mississippi, United States

Central Jersey Medical Research

🇺🇸

Elizabeth, New Jersey, United States

Long Island Clinical Research

🇺🇸

Great Neck, New York, United States

LeBauer Research Associates, PA

🇺🇸

Greensboro, North Carolina, United States

New York Presbyterian Hospital-Weill Medical College of Cornell University

🇺🇸

New York, New York, United States

Stony Brook University Hospital

🇺🇸

Stony Brook, New York, United States

Charlotte Gastroenterology & Hepatology

🇺🇸

Charlotte, North Carolina, United States

Northwest Piedmont Clinical Research

🇺🇸

Elkin, North Carolina, United States

East Carolina Gastroenterology, PA

🇺🇸

Jacksonville, North Carolina, United States

Carolina Digestive Diseases, PA

🇺🇸

Greenville, North Carolina, United States

Hanover Medical Specialists, PA

🇺🇸

Wilmington, North Carolina, United States

Wilmington Gastroenterology Associates

🇺🇸

Wilmington, North Carolina, United States

Wake Research Associates

🇺🇸

Raleigh, North Carolina, United States

Gastroenterology Specialists, Inc.

🇺🇸

Canton, Ohio, United States

Digestive Health Newtork

🇺🇸

Cincinnati, Ohio, United States

Gastrointestinal & Liver Disease Consultants

🇺🇸

Dayton, Ohio, United States

Avamar Center for Endoscopy

🇺🇸

Warren, Ohio, United States

Penn State Milton S. Hershey Medical Center

🇺🇸

Hershey, Pennsylvania, United States

Guthrie Clinic, Ltd

🇺🇸

Sayre, Pennsylvania, United States

ClinSearch

🇺🇸

Chattanooga, Tennessee, United States

Memphis Gastroenterology Group

🇺🇸

Memphis, Tennessee, United States

NationsMed Clinical Research

🇺🇸

Houston, Texas, United States

Houston Medical Research Associates

🇺🇸

Houston, Texas, United States

Baylor University Medical Center

🇺🇸

Irving, Texas, United States

Advanced Research Institute

🇺🇸

Ogden, Utah, United States

Tacoma Digestive Disease Research

🇺🇸

Tacoma, Washington, United States

Gastroenterology Associates of Tidewater

🇺🇸

Chesapeake, Virginia, United States

Seattle Gastroenterology Associates

🇺🇸

Seattle, Washington, United States

Horizon Institute for Clinical Research

🇺🇸

Hollywood, Florida, United States

West Wind'r Research & Development

🇺🇸

Tampa, Florida, United States

Digestive Health Specialists

🇺🇸

Winston-Salem, North Carolina, United States

Charleston Gastroenterology Center

🇺🇸

Charleston, South Carolina, United States

McGuire VAMC

🇺🇸

Richmond, Virginia, United States

Cotton-O'Neil Digestive Health Center

🇺🇸

Topeka, Kansas, United States

Medical Services of NWA

🇺🇸

Fayetteville, Arkansas, United States

Thomas Jefferson University

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath